Shilpa Medicare Ltd.

437.35 -12.90 ▼-2.9%

23 February 2024, 04:01:00 PM
Volume: 44,688

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vbshilpa.com
Market Cap 3,796.28 Cr.
Enterprise Value(EV) 4,635.80 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.08 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.98 Trailing Twelve Months Ending 2023-12
Book Value / Share 206.13 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.12 Calculated using Price: 437.35
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 8.68 Cr. 86,801,898 Shares
FaceValue 1
About Shilpa Medicare Ltd.
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Ltd. Delivery

Delivered Qty
Traded Qty

Shilpa Medicare Ltd. Performance

1 Day
-2.87%
1 Week
+17.10%
1 Month
+31.65%
3 Month
+17.95%
6 Month
+18.93%
1 Year
+57.01%
2 Year
-0.94%
5 Year
+24.49%
10 Year
+147.86%

Shilpa Medicare Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.4 17.66 12.85 9.93 9.59 12.23 10.41 3.67 -1.71
Return on Capital Employed (%) 17.9 19.69 15.28 11.13 10.45 12.38 10.73 5.94 0.8
Return on Assets (%) 9.18 11.41 8.69 6.92 7.04 8.59 6.33 2.2 -1.07

Shilpa Medicare Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 547 639 987 1,085 1,198 1,329 1,479 1,822 1,783 1,783
Non Curr. Liab. 154 67 251 153 167 257 561 453 345 599
Curr. Liab. 189 222 237 266 253 411 587 612 783 630
Minority Int. 14 2 -3 -5 -8 -8 -11 -11 -9 -9
Equity & Liab. 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,902 3,004
Non Curr. Assets 577 577 742 827 1,065 1,365 1,730 1,988 2,134 2,179
Curr. Assets 328 354 730 672 545 624 862 887 768 825
Misc. Exp. not W/O 0
Total Assets 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,902 3,004

Shilpa Medicare Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 614 716 779 789 733 908 901 1,146 1,050 1,123
Other Income 7 11 29 33 16 22 40 21 31 8
Total Income 621 728 809 821 749 930 941 1,166 1,082 1,131
Total Expenditure -487 -556 -618 -638 -579 -693 -729 -948 -962 -911
PBIDT 133 171 191 184 170 237 212 218 120 221
Interest -4 -4 -3 -3 -4 -5 -22 -41 -59 -85
Depreciation -21 -23 -31 -37 -42 -44 -54 -80 -96 -107
Taxation -35 -36 -42 -34 -26 -33 -49 -42 7 -23
Exceptional Items 0 -2 -5 20 61 9
PAT 73 105 104 103 110 155 146 61 -31 5
Minority Interest 1 4 3 2 3 2 2 0 -2 0
Share Associate -6
Other Related Items
Consolidated Net Profit 74 108 108 105 112 156 148 61 -32 -1
Adjusted EPS 10 14 13 13 14 19 18 7 -4 0

Shilpa Medicare Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 70 69 129 37 45 147 124 47 105 226
Cash Fr. Inv. -49 -195 -109 -262 -9 -196 -290 -404 -286 -278
Cash Fr. Finan. -28 136 -20 313 -61 10 176 436 83 46
Net Change -7 10 0 88 -25 -39 10 79 -98 -7
Cash & Cash Eqvt 9 18 6 100 74 34 44 123 25 19

Shilpa Medicare Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01
Public 49.99 49.99 49.99 49.99 49.99 49.99 49.99 49.99 49.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.81 0.81 0.81 0.81 1.38 12.90 12.90 90.41 90.41

Shilpa Medicare Ltd. Announcements

Thu, 22 Feb 2024
Intimation Of Submission Of Application For Reclassification
Submission of Application in Stock exchange under Regulation 31A of SEBI (LODR)
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q3 Conference call
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of Q3 FY 24 conference call

Shilpa Medicare Ltd. Technical Scans

Fri, 23 Feb 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Shilpa Medicare Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Shilpa Medicare Ltd. FAQ's

What is Shilpa Medicare share price?

Can I buy Shilpa Medicare shares now?

What is the Market Cap of Shilpa Medicare?

What are the key metrics to analyse Shilpa Medicare?

What is the 52 Week High and Low of Shilpa Medicare?

What is the trend of Shilpa Medicare share price?